DNB Carnegie helped Sixth Swedish Pension Fund invest in Asker Healthcare Group

Nordea acted as Joint Global Coordinator and Joint Bookrunner in the sale of approximately 38 million shares in Asker Healthcare Group on behalf of the Sixth Swedish National Pension Fund / Sjätte AP-fonden (“AP6”). Asker Healthcare Group is a partner to caregivers and patients across Europe providing quality medical products and solutions. See more ECM transactions: https://lnkd.in/eQyMG-Uz #Nordea #InvestmentBanking #ECM

🌐 Stifel is pleased to have acted as Sole Financial Advisor to a consortium led by Naxicap Partners on the sale of MEDIPREMA group, a leading European provider of neonatal care solutions, to private equity investors InnovaFonds and Sodero. 🏥 Médipréma Group combines the expertise of Médipréma and Beldico to design, manufacture, and distribute specialised equipment and consumables for Neonatal Intensive Care Units (NICUs). With 200+ employees and a presence in over 50 countries, the Group has established itself as a European leader in neonatal care. 🩺 This partnership with InnovaFonds and Sodero will support the Group’s strategic ambitions by accelerating international growth, driving innovation across its product portfolio, and enabling targeted acquisitions to strengthen its leadership in neonatal care. Laurent COLLEATTE, Laure Marchais, Xavier GELOT, Ronan AUFFRET, Cyriaque Viaud, Cyril Chaumien, Ophelie Gasselin

CBC Group has closed its second private credit fund, the R-Bridge Healthcare Fund II, raising $500 million and expanding its pan-Asian and global focus beyond China. Backed by over 10 limited partners, including Orange County Employees Retirement System, the fund targets healthcare and biopharma companies in Asia, Europe, and North America. Michael Keyoung, MD, PhD, CBC's head of private credit, shares how the firm’s non-dilutive, royalty-backed financing strategy stands out in the evolving healthcare private debt landscape. Vivian Li | ION Analytics https://lnkd.in/effaQpBG #PrivateDebt #PrivateCredit

A takeover bid for mpox and chikungunya vaccine-maker Bavarian Nordic by Permira and Nordic Capital has received regulatory approval, leaving disgruntled shareholders to slug it out between them. Danish pension fund ATP, the largest shareholder with a 10 percent stake, has rejected the bid, saying it undervalues the vaccine firm’s future prospects. Read more - https://lnkd.in/eEUSe-8z

TCGX, a healthcare investment firm, has closed its third fund, TCGX Fund III with $1.3 billion in capital commitments. The new fund builds on the success of Fund II, bringing TCG's total funds raised since 2021 to over $3.1 billion. TCGX Founder and Managing Partner Dr. Chen Yu said, “Exceeding our target for Fund III highlights the deep trust and conviction our investors have placed in our team and approach. We remain steadfast in our mission to back visionary entrepreneurs and companies advancing disruptive medicines to improve patient outcomes.” The Gunderson deal team included Andrew Thornborrow, Olga Zolotnik, Amanda C., Luke Charette, Bria Guitano and Casey S. https://bit.ly/4q2QfBq #fundformation #healthcare #medicine #TCGX

𝗖𝗮𝗶𝗿𝗻𝗴𝗼𝗿𝗺 𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗲𝘅𝗶𝘁𝘀 𝗘𝗠𝗘𝗗 𝗚𝗿𝗼𝘂𝗽 𝘁𝗼 𝗧𝗶𝗴𝗲𝗿 𝗜𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀 Cairngorm Capital Partners (Cairngorm Capital) is pleased to confirm it has completed its sale of its majority ownership of EMED Group –  the UK’s largest non-emergency patient transport (NEPTS) provider – to Tiger Infrastructure Partners, which will support the next growth phase of EMED. Full details below. #privateequity #buyandbuild

According to one study, autoimmune diseases cumulatively affect 5 to 10% of the industrial world population (1) (2). In the United States, the prevalence is estimated to be around 8%, or roughly 27 million people. Prevalence at these levels will need increasing rates of breakthrough medicines. So glad to see the VC investment from Arthritis National Research Foundation and the founding of Immune Boost Capital . #autoimmune #biotech #innovativemedicine

Westbridge has secured two high-quality medical centres in Victoria to seed our new Medical Property Fund seeded by the $22.5m acquisition of two prime Victorian medical centres — Sandhurst Medical Practice in Bendigo and Croydon Family Practice in Melbourne’s east.   The Fund is targeting $100m+ in assets Australia-wide, delivering a compelling combination of 12%+* IRR and 7%* p.a. monthly distributions through income and capital growth potential.   With equity raising under way for a third acquisition and a fourth in due diligence, momentum is building quickly as we expand this high-growth portfolio in Australia’s healthcare sector.   T&C’s apply.

Premier to go private in $2.6B deal with California investment firm: The take-private deal should give Premier more capital to bolster its operations and invest in technology.

Fundraising in Southeast Asia PE has hit a lull: just one fund - Quadria’s $1.07b healthcare vehicle - closed in H1 2025. The big question: will the second half bring relief? Our new DealStreetAsia-DATA VANTAGE report explores H1 trends, interim closes, fresh launches, and fund manager perspectives. 📊 Get the full picture in the report: https://lnkd.in/gvaMT2iB #PrivateEquity #SoutheastAsia #Report #DealStreetAsia